Reaktionsgleichung
[ClH:1].C(O)C.[CH2:5]([N:12]1[C:18](=[O:19])[C@H:17]2[CH2:20][CH2:21][CH2:22][C@H:16]2[NH:15][C:14]2[CH:23]=[CH:24][CH:25]=[CH:26][C:13]1=2)[C:6]1[CH:11]=[CH:10][CH:9]=[CH:8][CH:7]=1>C(O)C>[ClH:1].[CH2:5]([N:12]1[C:18](=[O:19])[C@H:17]2[CH2:20][CH2:21][CH2:22][C@H:16]2[NH:15][C:14]2[CH:23]=[CH:24][CH:25]=[CH:26][C:13]1=2)[C:6]1[CH:7]=[CH:8][CH:9]=[CH:10][CH:11]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
In ethanol was dissolved (3aR*,10aS*)-9-benzyl-2,3,3a,4,9,10a-hexahydrobenzo[b]cyclopenta[e][1,4]diazepin-10(1H)-one. To the solution was added dropwise a 2.5N HCl-ethanol solution, and the mixture was concentrated under reduced pressure. The concentrate was recrystallized from ethanol-ether to give the titled compound. m.p. 145°-148° C.
Aufarbeitung
- concentrationthe mixture was concentrated under reduced pressure
- customThe concentrate was recrystallized from ethanol-ether
Quellen und Nachweise
- ORD-Eintrag
- ord-73df44f84f6d41899bb8ef19f4c809a0
- Quelldatensatz
- uspto-grants-1998_11
- Patentnummer
- US05834463
Verknüpfte Notizen
Wird geladen…